• Top Picks
    • Progression-free Survival Data Updated Overall Survival Analysis for HR+mBC Treatment
    • Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates
    • XGEVA® Mechanism of Action Video Challenge
    • Applying Imaging, Biomarkers, and Immunotherapy in the Management of NSCLC

Select a Topic

  • FILTER BY:
  • All Education Lab
  • CME Only
Progression-free Survival Data Updated Overall Survival Analysis for HR+mBC Treatment

Watch this brief video about prolonged PFS and updated OS data analysis for HR+ mBC Treatment…

go to activity»
Mechanism of Action Video Challenge
VIDEO

XGEVA® Mechanism of Action Video Challenge

This activity is sponsored as an educational service by Amgen.

October 29, 2014

Learn about the mechanism of action of XGEVA®…

go to activity»
High Risk AAMDS
CMECNE

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

Expiration Date: 7/31/2015
Credit Type(s): CME / CNE | Credit: 0.5

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to patients and their families. This program reviews communication strategies that…

go to activity»
Melanoma: Updates on risks and treatment options

Melanoma is one of the most dangerous forms of skin cancer, causing 75% of deaths associated with skin cancer. There are approximately 48,000 deaths associated with melanoma worldwide every year…

go to activity»
Low Risk AAMDS
CMECNE

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

Expiration Date: 7/31/2015
Credit Type(s): CME / CNE | Credit: 0.5

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS to patients and their families. This program reviews communication strategies…

go to activity»
Stem Cell Transplant for AAMDS
CMECNE

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

Expiration Date: 7/31/2015
Credit Type(s): CME / CNE | Credit: 0.5

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to patients and their families. This program reviews communication strategies that…

go to activity»
morganatic-roan